Advertisement

 

 

Nanomedicines for dysfunctional macrophage-associated diseases.

Nanomedicines for dysfunctional macrophage-associated diseases.
Author Information (click to view)

He H, Ghosh S, Yang H,


He H, Ghosh S, Yang H, (click to view)

He H, Ghosh S, Yang H,

Advertisement

Journal of controlled release : official journal of the Controlled Release Society 2017 01 03247() 106-126 pii 10.1016/j.jconrel.2016.12.032

Abstract

Macrophages play vital functions in host inflammatory reaction, tissue repair, homeostasis and immunity. Dysfunctional macrophages have significant pathophysiological impacts on diseases such as cancer, inflammatory diseases (rheumatoid arthritis and inflammatory bowel disease), metabolic diseases (atherosclerosis, diabetes and obesity) and major infections like human immunodeficiency virus infection. In view of this common etiology in these diseases, targeting the recruitment, activation and regulation of dysfunctional macrophages represents a promising therapeutic strategy. With the advancement of nanotechnology, development of nanomedicines to efficiently target dysfunctional macrophages can strengthen the effectiveness of therapeutics and improve clinical outcomes. This review discusses the specific roles of dysfunctional macrophages in various diseases and summarizes the latest advances in nanomedicine-based therapeutics and theranostics for treating diseases associated with dysfunctional macrophages.

Submit a Comment

Your email address will not be published. Required fields are marked *

1 × 3 =

[ HIDE/SHOW ]